TLT.VTLT.VTSXV

Overview Intelligence Charts News Fundamentals Key Metrics Financials Growth Insiders

Latest News

feeds.newsfilecorp.com

Light-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy

Toronto, Ontario--(Newsfile Corp. - March 2, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a

feeds.newsfilecorp.com

Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study

Toronto, Ontario--(Newsfile Corp. - February 2, 2026) - Theralase Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase" or the "Company"), a clinical stage

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance